American Vanguard (AVD)
(Delayed Data from NYSE)
$8.75 USD
+0.05 (0.57%)
Updated Jun 5, 2024 04:00 PM ET
After-Market: $8.75 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
C Value D Growth B Momentum D VGM
Brokerage Reports
0 items in cart
American Vanguard Corporation [AVD]
Reports for Purchase
Showing records 101 - 120 ( 196 total )
Company: American Vanguard Corporation
Industry: Chemical - Specialty
Closes Previously Announced Product Acquisitions
Provider: Roth Capital Partners, Inc.
Analyst: REAGOR J
Company: American Vanguard Corporation
Industry: Chemical - Specialty
1Q:17 Missed Our Estimates, 2Q Outlook Favorable, More Acquisitions Likely in FY-17
Provider: Feltl & Company
Analyst: STEELE A
Company: American Vanguard Corporation
Industry: Chemical - Specialty
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: American Vanguard Corporation
Industry: Chemical - Specialty
Company: American Vanguard Corporation
Industry: Chemical - Specialty
Meeting with Management Outlines Future Growth Opportunities, Reiterate PT $18.60
Provider: Feltl & Company
Analyst: STEELE A
Company: American Vanguard Corporation
Industry: Chemical - Specialty
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: American Vanguard Corporation
Industry: Chemical - Specialty
Company: American Vanguard Corporation
Industry: Chemical - Specialty
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: American Vanguard Corporation
Industry: Chemical - Specialty
4Q:16 Missed Our Estimates, 2017 Outlook Positive, Lowering PT to $18.60
Provider: Feltl & Company
Company: American Vanguard Corporation
Industry: Chemical - Specialty
Company: American Vanguard Corporation
Industry: Chemical - Specialty
Company: American Vanguard Corporation
Industry: Chemical - Specialty
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: American Vanguard Corporation
Industry: Chemical - Specialty
Trump Political Agenda Could Drive Higher Sales; Upgrading to Buy
Provider: Roth Capital Partners, Inc.
Analyst: REAGOR J
Company: American Vanguard Corporation
Industry: Chemical - Specialty
Acquisition will help turf business, tweaking 4Q slightly lower
Provider: Feltl & Company
Analyst: RYSTROM B
Company: American Vanguard Corporation
Industry: Chemical - Specialty
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: American Vanguard Corporation
Industry: Chemical - Specialty
3Q sales beat, EPS missed; see more growth in 2017, but does stock pause til spring
Provider: Feltl & Company
Analyst: RYSTROM B
Company: American Vanguard Corporation
Industry: Chemical - Specialty
Q3 Update; Post Zika Hype Acquisitions Could be Key
Provider: Roth Capital Partners, Inc.
Analyst: REAGOR J
Company: American Vanguard Corporation
Industry: Chemical - Specialty
3Q preview: we expect revenue to grow modestly, EPS up, outlook trending favorable
Provider: Feltl & Company
Analyst: RYSTROM B
Company: American Vanguard Corporation
Industry: Chemical - Specialty
2Q beat on EPS, business showing signs of growth, 2017 acceleration likely
Provider: Feltl & Company
Analyst: RYSTROM B